TGA
Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 – external site, which commenced on 12 June 2026. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026 – external site.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.
A complete list of the 5 changed ingredients is below.
Changed ingredients
| Substance name | Change |
|---|---|
| Xanthium sibiricum | Change |
| Xanthium strumarium | Change |
| theanine | Change |
| oxaceprol | Addition |
| Lactococcus lactis subsp. lactis | Addition |
/Public Release. View in full here.
